Role of continuous glucose monitoring in the management of glycogen storage disorders
- 314 Downloads
Management of liver glycogen storage diseases (GSDs) primarily involves maintaining normoglycemia through dietary modifications and regular glucose monitoring. Self-monitoring of blood glucose is typically done 3–6 times per day, and may not sufficiently capture periods of asymptomatic hypoglycemia, particularly during sleep. Continuous glucose monitoring systems (CGMS) provide 24-h continuous glucose data and have been used effectively in diabetes mellitus to monitor metabolic control and optimize treatment. This is a relatively new approach in GSDs with only a handful of studies exploring this modality. In this study we used Dexcom CGMS to study the glycemic profile of 14 pediatric and six adult patients with GSD I, III, and IX. A total of 176 days of CGMS data were available. The CGMS was found to be a reliable tool in monitoring glucose levels and trends at all times of the day with good concordance with finger-stick glucose values. This study revealed that in addition to overnight hypoglycemia, CGMS can uncover previously undetected, subclinical, low glucose levels during daytime hours. Additionally, the CGMS detected daytime and overnight hyperglycemia, an often overlooked concern in liver GSDs. The CGMS with concurrent dietary adjustments made by a metabolic dietitian improved metabolic parameters and stabilized blood glucose levels. The CGMS was found to be a safe, effective, and reliable method for optimizing treatment in patients with GSD I, III, and IX.
No external funding sources were used for this study.
Compliance with ethical standards
Conflict of interest
M. Herbert, S. Pendyal, M. Rairikar, C. Halaby, R. W. Benjamin, and P. S. Kishnani declare that they have no conflict of interest.
This article does not contain any studies with human or animal subjects performed by the any of the authors.
- Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW, Replace-Bg Study Group (2017) REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 40:538–545CrossRefGoogle Scholar
- Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, Diamond Study Group (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317:371–378CrossRefGoogle Scholar
- Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P (2018) Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab 103:1224–1232CrossRefGoogle Scholar
- Choudhary P, Geddes J, Freeman JV, Emery CJ, Heller SR, Frier BM (2010) Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med 27:666–672CrossRefGoogle Scholar
- FDA (2016) Dexcom G5 Mobile Continuous Glucose Monitoring System. Retrieved from https://www.fda.gov/downloads/AdvisoryCommittees/.../UCM511810.pdf
- Kishnani PS, Chen YT (2016) Defects in metabolism of carbohydrates. In: Stanton B, Kliegman R, St. Geme J, Schor N, Behrman R (eds) Nelson textbook of pediatrics. Elsevier, PhiladelphiaGoogle Scholar
- Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Olafsdottir AF, Frid A, Wedel H, Ahlen E, Nystrom T, Hellman J (2017) Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317:379–387CrossRefGoogle Scholar
- Mangrola D, Cox C, Furman AS, Krishnan S, Karakas SE (2017) Self-blood glucose monitoring underestimates hyperglycemia and hypoglycemia as compared to continuous glucose monitoring in type 1 and type 2 diabetes. Endocr Pract. https://doi.org/10.4158/EP-2017-0032Google Scholar
- Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT, Group In-Home Closed-Loop Study (2017) Predictive hyperglycemia and hypoglycemia minimization: in-home evaluation of safety, feasibility, and efficacy in overnight glucose control in type 1 diabetes. Diabetes Care 40:359–366CrossRefGoogle Scholar